ReleaseWire Connect

This strategic analysis is part of Frost & Sullivan’s continued coverage of the enterprise communications marketplace. Within this analysis, Frost & Sullivan has identified industry challenges, market drivers, restraints, competitive landscape, revenues, market shares and key market trends of two of the main on-site enterprise mobility endpoint options available in the market today: VoWLAN single-mode devices (no smartphones) and DECT handsets. With extensive primary and secondary research, this analysis provides enterprise endpoint vendors with a detailed look at the current and changing dynamics in this fast evolving on-site mobility marketplace.

The global crop protection market consists of crop protection chemicals or agrochemicals, seeds, and genetically modified (GM) crops. Crop protection chemicals are the most dominating segment of this market in terms of market share as well as product innovations. Crop protection chemicals are further classified as pesticides (herbicides, insecticides, and fungicides), bio-pesticides, micronutrients, and adjuvants. As the latter three segments hold very minor market share, in general practice, pesticides are referred to as crop protection chemicals.

Starting off with pneumatic phase, the home automation and control systems market has reached the world of standards, protocols, and data distribution systems; which allows the home automation control structures such as security systems, and lighting systems to interact and integrate with each other. The home automation and control systems that started with wired technology have now entered the era of wireless technology with technologies such as Zigbee, Z-wave, EnOcean, and others coming up.

Clinical trials market now witnesses a paradigm shift. Naïve heterogeneous patient populations in the developing nations are opening up new avenues for the clinical trials market. Developing countries also offer faster means; which is triggering major pharmaceutical companies to direct their investment in these regions. Apart from this, stringent regulations and tight R&D budgets in the pharma-biotech industry are also forcing companies to move to east. This scenario has further boosted the alliances between the pharma-biotech companies and the clinical research organizations, with the latter accounting for major chunk of the trials conducted.

The advancements in technology have made available a variety of features that were earlier accessible through personal computers to be easily accessed through mobile phones; for instance, web browsing, emailing, and others. Popularity of applications such as Facebook, Twitter, and others has increased the usage of mobile phones in order to update the status messages instantly on the move.

MarketsandMarkets “Global Building Automation & Control Systems Market by Products, Applications & Technologies (2011 – 2016)” is now available at ReportsnReports.com.

Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceuticals market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market.

The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015.